Effects of sphingolipid metabolism disorders on endothelial cells

被引：18

作者：

Lai, Yali ^{[1
]}

Tian, Yue ^{[1
]}

You, Xintong ^{[1
]}

Du, Jiangnan ^{[1
]}

Huang, Jianmei ^{[1
]}

机构：

[1] Beijing Univ Chinese Med, Sch Tradit Chinese Mat Med, Beijing, Peoples R China

来源：

LIPIDS IN HEALTH AND DISEASE | 2022年 / 21卷 / 01期

基金：

中国国家自然科学基金;

关键词：

Sphingolipid metabolism; Endothelial cells; Sphingosine-1-phosphate; Sphingosine kinase; Ceramide; Serine; Ceramide kinase; Sphingosine-1-phosphate lyase; Cardiovascular disease; SPHINGOSINE-1-PHOSPHATE RECEPTOR 2; SPHINGOSINE KINASE; VASCULAR-PERMEABILITY; OVER-EXPRESSION; PRECURSOR CELLS; CERAMIDE; ACTIVATION; 1-PHOSPHATE; ANGIOGENESIS; DYSFUNCTION;

D O I：

10.1186/s12944-022-01701-2

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Many cardiovascular disorders, including atherosclerosis, hypertension, coronary heart disease, diabetes, etc., are characterized by endothelial cell dysfunction. Endothelial cell function is closely related to sphingolipid metabolism, and normal sphingolipid metabolism is critical for maintaining endothelial cell homeostasis. Sphingolipid metabolites or key enzymes in abnormal situation, including sphingosine, ceramide (Cer), sphingosine-1-phosphate (S1P), serine, sphingosine kinase (SPHK), ceramide kinase (Cerk), sphingosine-1-phosphate lyase (S1PL) etc., may have a protective or damaging effect on the function of endothelial cells. This review summarizes the effects of sphingolipid metabolites and key enzymes disordering in sphingolipid metabolism on endothelial cells, offering some insights into further research on the pathogenesis of cardiovascular diseases and corresponding therapeutic targets.

引用

页数：12

共 50 条

[21] Oxidative Stress and MicroRNAs in Endothelial Cells under Metabolic Disorders
Minjares, Morgan
Wu, Wendy
Wang, Jie-Mei
CELLS, 2023, 12 (09)
[22] Adiponectin mediated metabolic and sphingolipid alterations in preventing endothelial dysfunction
Vincent, Vinnyfred
Thakkar, Himani
Sen, Atanu
Bansal, Ashutosh
Das, Ujjalkumar Subhash
Gunasekaran, Abishek
Bhatla, Neerja
Velpandian, Thirumurthy
Singh, Archna
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2025,
[23] Sphingolipid metabolism and its relationship with cardiovascular, renal and metabolic diseases
Hernandez-Bello, Fernando
Franco, Martha
Perez-Mendez, Oscar
Donis-Maturano, Luis
Zarco-Olvera, Gabriela
Bautista-Perez, Rocio
ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2023, 93 (01): : 88 - 95
[24] Sphingolipid signaling modulates trans-endothelial cell permeability in dengue virus infected HMEC-1 cells
Anupriya, M. G.
Singh, Sneha
Hulyalkar, Neha Vijay
Sreekumar, Easwaran
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2018, 136 : 44 - 54
[25] Evolving concepts in cancer therapy through targeting sphingolipid metabolism
Truman, Jean-Philip
Garcia-Barros, Monica
Obeid, Lina M.
Hannun, Yusuf A.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2014, 1841 (08): : 1174 - 1188
[26] Evaluation of sphingolipid metabolism on diabetic retinopathy
Delioglu, Ezgi Naz Ensari
Ugurlu, Nagihan
Erdal, Ebru
Malekghasemi, Soheil
Cagil, Nurullah
INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (11) : 3376 - 3380
[27] Effects of Mycoplasma pneumoniae infection on sphingolipid metabolism in human lung carcinoma A549 cells
Yu, Yuanyuan
Sun, Gongping
Liu, Guangyi
Wang, Yingshuo
Shao, Zhengping
Chen, Zhimin
Yang, Jun
MICROBIAL PATHOGENESIS, 2009, 46 (02) : 63 - 72
[28] Sphingolipid metabolism diseases
Kolter, Thomas
Sandhoff, Konrad
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2006, 1758 (12): : 2057 - 2079
[29] Sphingosine-1-phosphate receptor 1 transmits estrogens' effects in endothelial cells
Sukocheva, Olga
Wadham, Carol
Gamble, Jennifer
Xia, Pu
STEROIDS, 2015, 104 : 237 - 245
[30] Nuclear Sphingolipid Metabolism
Lucki, Natasha C.
Sewer, Marion B.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 74, 2012, 74 : 131 - 151

← 1 2 3 4 5 →